White House Anti-Fraud Roundtable Draws Partisan Divide Over Access

The Trump administration’s handling of public health threats and anti-fraud initiatives has drawn fresh attention from state officials and former agency staff, who point to patterns of restricted information flow and delayed action. Recent developments in the response to Ebola outbreaks in Central Africa and a White House roundtable on fraud illustrate tensions over how expertise is incorporated into federal decision-making.

An ongoing Ebola outbreak in the Democratic Republic of the Congo and Uganda has recorded nearly 1,000 suspected cases and more than 200 deaths, according to Centers for Disease Control and Prevention data. Public health workers have cited funding constraints at the US Agency for International Development as a factor complicating containment efforts. State Department spokesman Tommy Pigott has rejected claims that USAID reforms impaired the response, stating last week that such assertions are false.

Testimony from March 2025, however, offered a different account. Nicholas Enrich, then acting assistant administrator for global health at USAID, told the House Committee on Foreign Affairs that funding requests for an earlier Uganda outbreak went unaddressed. He described how Tim Meisburger, head of USAID’s Bureau of Humanitarian Assistance at the time, labeled the outbreak a “scam” after only one death had been recorded. Enrich noted that the disease was still in an incubation period and that additional cases were expected. Protective equipment remained inaccessible amid the funding freeze.

Separately, two dozen Democratic state attorneys general declined invitations to a White House anti-fraud roundtable convened by Vice President JD Vance. They cited insufficient notice and the absence of a detailed agenda. Several states instead sent senior officials with direct experience in fraud prosecutions. Those officials were ultimately barred from the meeting. New York Attorney General Letitia James and California Attorney General Rob Bonta said the exclusions extended to experts from Minnesota, Massachusetts, Maryland, and Nevada. Conflicting explanations were provided for the denials, and Bonta characterized the event as one in which states would not serve as “props in Vance’s political performance.”

These episodes occur against a backdrop of broader administration efforts to reorganize foreign aid and domestic enforcement priorities. Analysts note that reduced staffing and altered approval processes at USAID have affected rapid-response capabilities for infectious disease threats, where early intervention depends on pre-positioned resources. In the fraud context, state attorneys general offices have accumulated substantial case experience through multistate settlements and investigations. Limiting their participation in federal discussions may narrow the range of enforcement strategies considered at the national level.

Public health specialists emphasize that Ebola transmission dynamics require sustained surveillance even when initial case counts appear low. Similarly, effective fraud prevention often relies on coordination across jurisdictions that hold different regulatory authorities. The administration maintains that its reforms aim to eliminate waste and focus resources on core priorities. State-level officials, however, continue to document instances where procedural changes have limited input from career experts.

The combined effect, according to participants in both episodes, is a narrowing of the information channels available to federal policymakers at moments when technical judgment is most relevant. Whether these frictions produce measurable differences in outbreak control or enforcement outcomes will depend on data collected over the coming months.